< > Regulator to expand probe into Samsung BioLogics' accounting practices
Go Search Go Contents Go to bottom site map

Regulator to expand probe into Samsung BioLogics' accounting practices

2018/06/13 11:29

Article View Option

SEOUL, June 13 (Yonhap) -- Financial authorities have decided to expand their probe into Samsung BioLogics Co.'s suspected accounting breach to include its books before 2015, officials said Wednesday.

The regulatory review centers on questions about the biopharmaceutical company's sudden profit in 2015 after years of losses. Samsung BioLogics reported a net profit of 1.9 trillion won that year after changing the method of calculating the value of its affiliate, Samsung Bioepis.

Samsung BioLogics has claimed that the change was in line with international accounting standards.

In a statement, the Financial Services Commission (FSC) said it decided to review accounting practices of Samsung BioLogics before 2015 to better judge whether the suspected accounting breach was intentional.

Reviewing past accounting practices will also help financial authorities make a final ruling on the suspected breach, the FSC said.

Financial authorities gave a preliminary notice earlier last month to Samsung BioLogics that it broke accounting rules in 2015, a charge strongly denied by the unit of Samsung Electronics Co.

Since then, financial authorities have held three rounds of reviews regarding the alleged accounting breach, but the reviews apparently failed to reach a consensus, prompting FSC officials to say there were some "majority and minority opinions" about the case.